Stock Traders Purchase High Volume of Call Options on Option Care Health (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) was the recipient of unusually large options trading on Tuesday. Traders acquired 5,219 call options on the stock. This is an increase of approximately 1,757% compared to the average volume of 281 call options.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently modified their holdings of OPCH. Squarepoint Ops LLC grew its position in Option Care Health by 234.1% during the 2nd quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock worth $9,110,000 after acquiring an additional 304,376 shares during the last quarter. Raiffeisen Bank International AG raised its position in Option Care Health by 92.3% in the second quarter. Raiffeisen Bank International AG now owns 250,000 shares of the company’s stock valued at $5,330,000 after purchasing an additional 120,000 shares during the last quarter. Norges Bank bought a new position in Option Care Health in the fourth quarter valued at about $61,787,000. Sumitomo Mitsui Trust Group Inc. acquired a new stake in shares of Option Care Health during the first quarter valued at about $70,287,000. Finally, Paralel Advisors LLC acquired a new stake in shares of Option Care Health during the second quarter valued at about $1,800,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

NASDAQ OPCH traded up $7.63 during midday trading on Tuesday, hitting $31.00. The company had a trading volume of 31,246,278 shares, compared to its average volume of 2,577,820. The company has a market capitalization of $4.64 billion, a PE ratio of 23.31, a P/E/G ratio of 1.30 and a beta of 0.58. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $23.61 and a 200-day moving average price of $23.54. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. During the same period in the previous year, the company earned $0.41 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, analysts anticipate that Option Care Health will post 1.7 earnings per share for the current fiscal year.

Trending Headlines about Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: McKesson and CD&R agreed to acquire Option Care Health for $32.05 per share, implying an enterprise value of approximately $5.8 billion and a premium of about 37% to the prior closing price. The all-cash transaction provides a clear takeover valuation and is the primary reason for the stock’s move higher. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Reports that acquisition discussions had reached an advanced stage, followed by the definitive agreement, triggered substantial investor interest and temporarily halted OPCH trading pending news. Option Care Health’s Shares Soar as Acquisition Talks Advance
• Neutral Sentiment: The deal remains subject to customary closing conditions and approvals. The stock’s trading level below the $32.05 offer price suggests investors may be accounting for transaction-completion risk.
• Neutral Sentiment: A Zacks article reviews whether OPCH is undervalued using value, growth, momentum and earnings-estimate trends, but the available report excerpt does not provide a definitive rating or new company-specific catalyst. Is Option Care Health Stock Undervalued Right Now?
• Negative Sentiment: Brodsky & Smith announced an investor investigation involving Option Care Health. The notice provides few details, but such investigations can introduce legal and reputational uncertainty around the transaction. Brodsky & Smith Shareholder Update

Wall Street Analyst Weigh In

Several research firms have issued reports on OPCH. Citigroup restated a “market outperform” rating on shares of Option Care Health in a research note on Tuesday. Weiss Ratings upgraded Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. The Goldman Sachs Group assumed coverage on Option Care Health in a report on Monday, June 8th. They set a “neutral” rating and a $22.00 target price on the stock. Stephens reaffirmed an “equal weight” rating and set a $24.00 price target (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Finally, Zacks Research raised shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $29.92.

Option Care Health Company Profile

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.